Position in SPRY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,250,149
-$1,819,603 QoQ
Shares Held
529,284
+1.6% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. SPRY ranks #147 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in SPRY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,250,149 | 529,284 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,069,752 | 521,009 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,341,603 | 531,503 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,463,493 | 485,014 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $6,126,999 | 487,043 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,044,513 | 478,153 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $6,559,509 | 452,380 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,277,028 | 267,571 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,678,752 | 262,109 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,423,051 | 259,681 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $987,109 | 261,140 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,545,629 | 230,691 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $468,524 | 71,970 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $574,094 | 67,303 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $207,418 | 39,284 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $157,982 | 37,260 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $609,227 | 173,569 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,197,853 | 179,858 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,853,754 | 185,747 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,888,987 | 125,898 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,871,898 | 134,584 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||